Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RNS60 vs Interferon Beta-1a in RRMS
NCT01714089Phase 2Withdrawn
- Sponsor
- Revalesio Corporation
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of RNS60 in multiple sclerosis (MS), sponsored by Revalesio Corporation. Status: withdrawn.
02
Drugs
RNS60
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01714089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714089.